Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

ICU

SeaStar Medical (ICU)

SeaStar Medical Holding Corporation
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:ICU
일자시간출처헤드라인심볼기업
2024/04/1805:00GlobeNewswire Inc.SeaStar Medical Reports 2023 Financial Results and Provides a Business UpdateNASDAQ:ICUSeaStar Medical Holding Corporation
2024/04/1121:30GlobeNewswire Inc.SeaStar Medical to Present at the Noble Capital Markets’ Emerging Growth Virtual Healthcare Equity ConferenceNASDAQ:ICUSeaStar Medical Holding Corporation
2024/03/2721:30GlobeNewswire Inc.SeaStar Medical to Restate Financials, Sets Business Update Call for April 17NASDAQ:ICUSeaStar Medical Holding Corporation
2024/03/1221:30GlobeNewswire Inc.SeaStar Medical Provides Updates on Enrollment of Adult Pivotal Clinical Study and Commercial Launch of Quelimmune, FDA-Approved in Pediatric PatientsNASDAQ:ICUSeaStar Medical Holding Corporation
2024/03/1205:05GlobeNewswire Inc.SeaStar Medical-Sponsored Symposium Featuring Experts Discussing Pediatric Acute Kidney Injury and the Selective Cytopheretic Device to be Webcast Live at AKI & CRRT 2024NASDAQ:ICUSeaStar Medical Holding Corporation
2024/02/2722:30GlobeNewswire Inc.Manuscript Discussing the Benefit of SeaStar Medical’s Selective Cytopheretic Device in Patients with Heart Failure and Hyperinflammation Published in European Journal of Heart FailureNASDAQ:ICUSeaStar Medical Holding Corporation
2024/02/2221:58GlobeNewswire Inc.Nuwellis’ Distribution Partner, SeaStar Medical, Receives FDA Humanitarian Device Exemption for Pediatric Selective Cytopheretic Device Quelimmune™NASDAQ:ICUSeaStar Medical Holding Corporation
2024/02/2221:53GlobeNewswire Inc.FDA Grants Humanitarian Device Exemption Approval to SeaStar Medical’s Selective Cytopheretic Device for Pediatric Acute Kidney InjuryNASDAQ:ICUSeaStar Medical Holding Corporation
2024/02/0122:30GlobeNewswire Inc.SeaStar Medical Granted Canadian Patent with Broad Claims Covering the Selective Cytopheretic Device TechnologyNASDAQ:ICUSeaStar Medical Holding Corporation
2024/01/2622:05GlobeNewswire Inc.SeaStar Medical Announces Pricing of $9.0 Million Registered Direct Offering Priced At-the-MarketNASDAQ:ICUSeaStar Medical Holding Corporation
2024/01/1206:05GlobeNewswire Inc.SeaStar Medical Appoints David A. Green as Chief Financial OfficerNASDAQ:ICUSeaStar Medical Holding Corporation
2024/01/0922:30GlobeNewswire Inc.SeaStar Medical Issued U.S. Patent with Broad Claims Covering Use of the Selective Cytopheretic Device for Multiple Clinical IndicationsNASDAQ:ICUSeaStar Medical Holding Corporation
2023/12/2822:30GlobeNewswire Inc.SeaStar Medical Updates Subject Enrollment in its Pivotal Trial with the Selective Cytopheretic Device in Adults with Acute Kidney InjuryNASDAQ:ICUSeaStar Medical Holding Corporation
2023/12/1322:30GlobeNewswire Inc.SeaStar Medical Forms Scientific Advisory Board of World-Renowned Pediatric and Adult Clinical ExpertsNASDAQ:ICUSeaStar Medical Holding Corporation
2023/11/1506:04GlobeNewswire Inc.SeaStar Medical Reports Third Quarter 2023 Financial Results and Provides a Business UpdateNASDAQ:ICUSeaStar Medical Holding Corporation
2023/10/3121:00GlobeNewswire Inc.Nuwellis’ Strategic Partner, SeaStar Medical, Receives FDA Approvable Letter for Its Pediatric Selective Cytopheretic DeviceNASDAQ:ICUSeaStar Medical Holding Corporation
2023/10/3021:00GlobeNewswire Inc.FDA Issues Approvable Letter for SeaStar Medical’s Selective Cytopheretic Device for Pediatric PatientsNASDAQ:ICUSeaStar Medical Holding Corporation
2023/10/1821:30GlobeNewswire Inc.FDA Grants SeaStar Medical’s Selective Cytopheretic Device Breakthrough Device Designation for Hepatorenal SyndromeNASDAQ:ICUSeaStar Medical Holding Corporation
2023/10/0521:30GlobeNewswire Inc.SeaStar Medical to Present at the Dawson James Small Cap Growth Conference on October 12, 2023NASDAQ:ICUSeaStar Medical Holding Corporation
2023/10/0405:05GlobeNewswire Inc.SeaStar Medical Provides Regulatory Update Regarding Selective Cytopheretic Device Use in Pediatric Acute Kidney Injury Under a Humanitarian Device ExemptionNASDAQ:ICUSeaStar Medical Holding Corporation
2023/09/2921:30GlobeNewswire Inc.FDA Grants Breakthrough Device Designation to SeaStar Medical’s Selective Cytopheretic Device for Cardiorenal SyndromeNASDAQ:ICUSeaStar Medical Holding Corporation
2023/09/2122:35GlobeNewswire Inc.Dawson James Securities Announces October Date for 8th Annual Small Cap Growth ConferenceNASDAQ:ICUSeaStar Medical Holding Corporation
2023/08/3105:35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ICUSeaStar Medical Holding Corporation
2023/08/2921:00GlobeNewswire Inc.Case Series of Three Critically Ill Children with Acute Kidney Injury Safely Treated with SeaStar Medical’s Selective Cytopheretic Device Published in the Journal Blood PurificationNASDAQ:ICUSeaStar Medical Holding Corporation
2023/08/2506:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ICUSeaStar Medical Holding Corporation
2023/08/2221:00GlobeNewswire Inc.SeaStar Medical to Hold Business Update Conference Call Today at 4:00 p.m. Eastern TimeNASDAQ:ICUSeaStar Medical Holding Corporation
2023/08/1806:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ICUSeaStar Medical Holding Corporation
2023/08/1806:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ICUSeaStar Medical Holding Corporation
2023/08/1806:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ICUSeaStar Medical Holding Corporation
2023/08/1605:45Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ICUSeaStar Medical Holding Corporation
 검색 관련기사 보기:NASDAQ:ICU